Managing Depression, Anxiety, and Psychosis in Parkinson’s Disease

<div id="description" class= "segment s bg-color-white darken1 group"> <div id="description" class= "segment s bg-color-white darken1 group"> <div>We discuss the prevalence and treatment of depression, psychosis in patients with Parkinson’s Disease.</div> </div> </div> <ul> <li><a href= "https://psychopharmacologyinstitute.com/publication/managing-depression-anxiety-and-psychosis-in-parkinsons-disease-2602?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC044"> <strong>Download a PDF of this interview here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC044"> <strong>Become a premium member of the Psychopharmacology Institute</strong></a></li> </ul>